News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioAlliance Pharma: New Agreement Signed for the Distribution of Loramyc® in Iran With Shafayab Gostar


10/18/2012 4:03:09 PM

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the signature of an agreement* with the Company Shafayab Gostar to distribute Loramyc® in Iran (miconazole Lauriad™ mucoadhesive buccal tablet for the treatment of oropharyngeal candidiasis in immunocompromised patients).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES